Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MU vs MRNA✓SelectedUSD · MRNAMU vs MRNA performance historyLatest closeAs of-7.62%11/16
Stock and ETF performance explorer

MU vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+197.5%
MRNA return
+778.7%
Excess return
-581.1%
Maximum drawdown
-45.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-7.6%-3.6%-4.0%-7.5%
7D-1.9%-20.0%+18.0%-1.2%
30D-18.2%-1.3%-16.9%-18.1%
3M-26.0%+240.0%-266.0%-30.0%
6M-0.7%+339.0%-339.7%-16.7%
YTD+152.1%+630.0%-477.9%+66.3%
All+197.5%+778.7%-581.1%+73.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling